VeriMomDevo evitar gemfibrozil na gravidez? | VeriMom
Animal reproductive and developmental toxicity (rats/rabbits) reported (dose-related decreases in conception, increased stillbirths, fetal skeletal variations and rare anophthalmia); regulatory/product literature flags suspected reproductive toxicity (H361) though no clear harmonised CLP entry was found. Mechanism is not well‑characterized for reproductive effects; likely related to pharmacologic/lipid‑metabolism effects seen with systemic exposure. Topical cosmetic exposure would give low but measurable systemic absorption in typical circumstances, so exposure is not negligible for pregnancy concerns. Sources: Drugs.com summary (drug pregnancy warnings), product monograph and animal study summaries, SDS/classification listings.
ECHA regulatory hazard statements
- •H360D
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- gemfibrozil é seguro durante a gravidez?
- Animal reproductive and developmental toxicity (rats/rabbits) reported (dose-related decreases in conception, increased stillbirths, fetal skeletal variations and rare anophthalmia); regulatory/product literature flags suspected reproductive toxicity (H361) though no clear harmonised CLP entry was found. Mechanism is not well‑characterized for reproductive effects; likely related to pharmacologic/lipid‑metabolism effects seen with systemic exposure. Topical cosmetic exposure would give low but measurable systemic absorption in typical circumstances, so exposure is not negligible for pregnancy concerns. Sources: Drugs.com summary (drug pregnancy warnings), product monograph and animal study summaries, SDS/classification listings.
- gemfibrozil é seguro durante a amamentação?
- Authoritative lactation sources (LactMed / drug monographs) advise avoidance during breastfeeding because of concern for disruption of infant lipid metabolism and because gemfibrozil is systemically absorbed and may transfer to milk. Reproductive/developmental animal data support suspected hazard. Topical cosmetic use would generally give low exposure, but milk transfer risk under systemic use is established. Sources: LactMed, product monograph, Drugs.com.
- gemfibrozil é seguro para a pele do bebê?
- Because animal developmental toxicity has been observed, hazard for infants is flagged as suspected (H361 in several supplier/SDS listings and regulatory summaries). For infant skin (0–3 yr) exposure, immature skin increases absorption; therefore exposure score is increased by +1 relative to adult topical exposure. There are no infant‑specific dermal studies for gemfibrozil in cosmetics, and no SCCS/CIR cosmetic safety opinion was located; concern is driven by systemic reproductive/developmental toxicity observed in animal studies and regulatory/product literature. Sources: SDSs and product monograph reporting reproductive effects, LactMed, animal study summaries.
- Como o VeriMom pontua gemfibrozil?
- O VeriMom pontua gemfibrozil em 27/100 (risco alto) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a gemfibrozil na gravidez?
- Veja nossa lista curada de alternativas seguras a gemfibrozil com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.